We found a new portfolio star! Invest now right from the start! Famous branding expert supports this cannabis company!

How about if you can invest right at the very beginning of a mega-profit opportunity in the cannabis sector? – We expect this stock will get us huge profits in this global cannabis boom! The unique patent portfolio, network and visionary management / consulting team makes PIVOT Pharmaceuticals an extremely promising top investment! More background

CANOPY GROWTH reports fourth quarter and fiscal 2019 results with annual sales of 226.3 Mio. $

20.06.2019 CANOPY GROWTH CORPORATION REPORTS FOURTH QUARTER AND FISCAL 2019 RESULTS WITH ANNUAL SALES OF$226.3M ●Achieved annual net revenue growth of 191% to $226.3 million. Generated $140.5 million of gross revenue from new Canadian recreational channel and $78.9 million in global medical sales.●Fourth quarter revenue growth of 13% versus third quarter with additional revenue being